Diabetes-induced vascular dysfunction in the retina: Role of endothelins

Diabetologia

Volumn 42, Issue 10, 1999, Pages 1228-1234

  Deng, D ^a   Evans, T ^a   Mukherjee, K ^a   Downey, D ^a   Chakrabarti, S ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Blood flow; Endothelin A; Endothelin B; Endothelin 1; Endothelin 3; Retina

Indexed keywords

BOSENTAN; ENDOTHELIN 1; ENDOTHELIN 3; ENDOTHELIN DERIVATIVE; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; GLYCOSYLATED HEMOGLOBIN; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DIABETIC RETINOPATHY; GENE EXPRESSION; GLUCOSURIA; HYPERGLYCEMIA; MALE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; RAT; RETINA BLOOD FLOW; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; STREPTOZOCIN DIABETES;

ANIMALS; ANTIHYPERTENSIVE AGENTS; AUTORADIOGRAPHY; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; ENDOTHELIN-1; ENDOTHELIN-3; IMMUNOHISTOCHEMISTRY; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN; RETINA; RETINAL VESSELS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SULFONAMIDES; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 0032868885     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051296     Document Type: Article

References (39)

1. Vanhoutte PM (1994) A matter of life and breath. Nature 368: 693-694
2. Simonson MS (1993) Endothelins: Multifunctional peptides in the kidney. Physiol Rev 73: 375-411
3. Rubanyi GM, Polokof MA (1994) Endothelins: Molecular biology, biochemistry, pharmacology, physiology and pathophysiology. Pharmacol Rev 46: 326-414
4. Huggins JP, Pelton JT, Miller RC (1993) The structure and specificity of endothelin receptors: Their importance in physiology and medicare. Pharmacol Ther 59: 55-123
5. Levin ER (1995) Endothelins. New Engl J Med 333: 356-363
6. Levin ER (1996) Endothelins as cardiovascular peptides. Am J Nephrol 16: 246
7. Chakrabarti S, Sima AAF (1997) Endothelin-1 and Endothelin-3 like immunoreactivity in the eyes of diabetic and non-diabetic BB/W rats. Diabetes Res Clin Prac 37: 109-120
8. Chakravarthy U, Douglas AJ, Bailie R, McKibben B, Archer DB (1994) Immunoreaetive endothelin distribution in ocular tissue. Invest Ophthalmol Vis Sci 35: 2448-2454
9. MacCumber MW, Ros CA, Glaser BM, Snyder SH (1989) Endothelin: Visualization of mRNAs by in situ hybridization provides evidence for local action. Proc Natl Acad Sci USA 86: 7285-7289
10. B gene expression in chronic diabetes. Curr Eye Res 17: 301-307
11. Williamson JR, Chang K, Frargos M et al. (1993) Perspective in diabetes: Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42: 801-813
12. Brownlee M, Cerami A, Vlassara H (1988) Advanced products of non-enzymatic glycosylation and the pathogenesis of diabetic vascular disease. Diabetes Metab Rev 4: 323-337
13. Greene DA, Lattimer SA, Sima AAF (1987) Sorbitol myoinositol and sodium potassium ATPase in the pathogenesis of diabetic complication. N Engl J Med 316: 559-606
14. Koya D, King GL (1998) Protein kinase C activation and the development of diabetic complications. Diabetes 47: 859-866
15. King GL, Brownlee M (1996) The cellular and molecular mechanisms of diabetic complications. Endocrinol Metab Clin North Am 25: 255-269
16. Gupta S, Ruderman S, Cragoe EJ, Susman I (1991) Endothelin stimulates Na + -K + -ATPase activity by a protein kinase C-dependent pathway is rabbit aorta. Am J Physiol 261: H38-H45
17. Awazu M, Parker RE, Harvie BR, Ichikawa I, Kon V (1991) Down regulation of endothelin-1 receptor prevented by protein kinase C inhibitor in streptozotocin diabetic rats. J Cardiovasc Pharmacol 17 [suppl 7] S500-S502
18. Kohner M, Patel V, Rassam SMB (1995) Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy. Diabetes 44: 607
19. Bursell SE, Clermont AC, Osen B, King GL (1995) The in vivo effect of endothelin retinal circulation in non-diabetic and diabetic rats. Invest Ophthalmol Vis Sci 36: 596-607
20. Cameron NE, Dines KC, Cotter MA (1994) The potential contribution of endothelin-1 to neurovascular abnormalities in streptozotocin-diabetic rats. Diabetologia 37: 1209-1215
21. Pedram A, Razandi M, Hu RM, Levin ER (1997) Vasoac-tire peptides modulate vascular endothelial cell growth factor production and endothelial cell proliferation and invasion. J Biol Chem 27: 17097-17103
22. Matsuura A, Yamochi W, Hirata K, Kawashina S, Yokoyana M (1997) Stimulatory interaction between vascular endothelial growth factor and endothelin-1 on each gene expression. Biochem Biophys Res Commun 235: 713-716
23. Nakamura T, Ebihara I, Fukui M, Tomuno Y, Koide H (1995) Effect of a specific endothelin receptor A antagonist on mRNA levels for extracellular matrix components and growth factors in diabetic glomeruli. Diabetes 44: 895-899
24. Clozel M, Gray GA, Kalina B et al. (1994) Pharmacological characterization of Bosentan, an orally active non-peptide endothelin receptor antagonist. J Pharmacol Exp Ther 270: 228-235
25. Zwiebel WJ (1992) Spectrum analysis in doppler vascular diagnosis. In: Zwiebel WJ (ed) Introduction to vascular ultrasonography 3rd edn. Saunders, Philadelphia, pp 46-65
26. Wang X-K, Douglas S, Louden C, Vickery-Clark LM, Feuerstein GZ, Ohlstein EH (1996) Expression of endothelin-1, endothelin-3, endothelin converting enzyme-1, and endothelin-A and endothelin-B receptor mRNA after angioplasty induced neointimal formation in the rat. Circ Res 78: 322-338
27. Yang T, Terada Y, Nonoguchi H, Ujiie K, Tomita K, Marumo F (1993) Effect of hyperasmolality on production and mRNA expression of ET-1 in inner medullary collecting ducts. Am J Physiol 264: F684-F689
28. Tarada Y, Tomita K, Nonoguchi H et al. (1993) Expression of endothelin-3 mRNA along rat nephron segment using polymerase chain reaction. Kidney 44: 1273-1280
29. Roy S, Lorenzi M (1996) Early biosynthetic changes in the diabetic like retinopathy of galactose fed rats. Diabetologia 39: 735-738
30. Chakrabarti S, Ghahary A, Murphy LJ, Sima AAF (1991) Insulin like growth factor I expression is not increased in the retina of diabetic BB/W rats. Diab Res Clin Pract 14: 91-98
31. MacCumber MW, D'Anna SA (1994) Endothelin receptor-binding subtypes in the human retina and choroid. Arch Ophthalmol 112: 1231-1235
32. Arai T, Numata K, Tanaka K et al. (1998) Ocular arterial flow dynamics in patients with diabetes mellitus. J Ultrasound Med 17: 675-681
33. Guthoff RF, Berger RW, Winkler P, Helmke K, Chumbley LC (1991) Doppler sonography of the ophthalmic and central retinal vessels. Arch Ophthalmol 109: 532-537
34. Lieb WE (1993) Color Doppler ultrasonography of the eye and orbit. Curr Opin Ophthalmol 4: 68-82
35. Schmetterer L, Wolzt M (1999) Ocular blood flow and associated functional deviations in diabetic retinopathy. Diabetologia 42: 387-405
36. Properzi G, Terenghi G, Gu XH et al. (1995) Human microvs. Early increase precedes a depletion of endothelin-but not of von Willebrand factor in cutaneous microvessels of diabetic patients. A quantitative immunohistochemical study. J Pathol:175: 243-252
37. Ishii H, Jirousek MR, Koya D et al. (1996) Ameloriation of vascular dysfunction in diabetic rats by an oral PKC β inhibitor. Science 272: 728-731
38. De La Rubia G, Oliver FJ, Inoguchi, King GL (1992) Induction of resistance to endothelin-1's biochemical actions by elevated glucose levels in retinal pericytes. Diabetes 41: 1533-1539
39. Simonson MS, Jones JM, Dunn MJ (1992) Differential regulation of fos and jun gene expression and AP-1 Cis element activity by endothelin isopeptides: Possible implications for mitogenic signalling by endothelin. J Biol Chem 267: 8643-8649